D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
eNeurologicalSci
.
2021 Feb 15:23:100328.
doi: 10.1016/j.ensci.2021.100328.
eCollection 2021 Jun.
Authors
Yihui Goh
1
,
Benjamin Yong-Qiang Tan
1
2
,
Nicole Ya-Yuan Chong
3
,
Margaret Ma
2
4
,
Manjari Lahiri
2
4
,
Andrew Makmur
5
,
Yee Cheun Chan
1
2
,
Soon Boon Justin Wong
6
,
Joy Vijayan
1
2
Affiliations
1
Division of Neurology, University Medicine Cluster, National University Health System, Singapore.
2
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
3
University Medicine Cluster, National University Health System, Singapore.
4
Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore.
5
Department of Diagnostic Imaging, National University Hospital, Singapore.
6
Department of Pathology, National University Hospital, Singapore.
PMID:
33786384
PMCID:
PMC7994719
DOI:
10.1016/j.ensci.2021.100328
No abstract available